Ongoing Contact Activation in Patients with Hereditary Angioedema

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Konings, Joke ^a   Cugno, Massimo ^b   Suffritti, Chiara ^c   ten Cate, Hugo ^a   Cicardi, Marco ^c   Govers Riemslag, José W P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 12A; COMPLEMENT COMPONENT C1S INHIBITOR; KALLIKREIN; RECOMBINANT PROTEIN;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VITRO STUDY; PATHOPHYSIOLOGY; REMISSION;

ADULT; AGED; ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; FACTOR XIA; FACTOR XIIA; FEMALE; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; MULTIPROTEIN COMPLEXES;

EID: 84883167757     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074043     Document Type: Article

References (37)

1. Longhurst H, Cicardi M, (2012) Hereditary angio-oedema. Lancet 379: 474-481. doi:10.1016/S0140-6736(11)60935-5. PubMed: 22305226.
2. Dewald G, Bork K, (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343: 1286-1289. doi:10.1016/j.bbrc.2006.03.092. PubMed: 16638441.
3. Bork K, Wulff K, Meinke P, Wagner N, Hardt J, et al. (2011) A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol 141: 31-35. doi:10.1016/j.clim.2011.07.002. PubMed: 21849258.
4. Zeerleder S, (2011) C1-inhibitor: more than a serine protease inhibitor. Semin Thromb Hemost 37: 362-374. doi:10.1055/s-0031-1276585. PubMed: 21805442.
5. Forbes CD, Pensky J, Ratnoff OD, (1970) Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. J Lab Clin Med 76: 809-815. PubMed: 5477337.
6. van der Graaf F, Keus JF, Koedam JA, Rietveld A, Bouma BN, (1983) Prekallikrein activation and kallikrein inactivation in human plasma. Adv Exp Med Biol 156: 143-148. PubMed: 6190365.
7. Pixley RA, Schapira M, Colman RW, (1985) The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem 260: 1723-1729. PubMed: 2578463.
8. Wuillemin WA, Minnema M, Meijers JC, Roem D, Eerenberg AJ, et al. (1995) Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor. Blood 85: 1517-1526. PubMed: 7534133.
9. Kaufman N, Page JD, Pixley RA, Schein R, Schmaier AH, et al. (1991) Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 77: 2660-2667. PubMed: 1710516.
10. Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, et al. (2007) Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 104: 6388-6393. doi:10.1073/pnas.0608647104. PubMed: 17405864.
11. Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, et al. (2010) Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 116: 4353-4359. doi:10.1182/blood-2010-01-266791. PubMed: 20709905.
12. Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP, (2001) Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Thromb Haemost 85: 119-124. PubMed: 11204562.
13. Oschatz C, Maas C, Lecher B, Jansen T, Björkqvist J, et al. (2011) Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity 34: 258-268. doi:10.1016/j.immuni.2011.02.008. PubMed: 21349432.
14. Bossi F, Fischetti F, Regoli D, Durigutto P, Frossi B, et al. (2009) Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol 124: 1303-1310 e1304 doi:10.1016/j.jaci.2009.08.007. PubMed: 19796797.
15. Cugno M, Zanichelli A, Bellatorre AG, Griffini S, Cicardi M, (2009) Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency. Allergy 64: 254-257. doi:10.1111/j.1398-9995.2008.01859.x. PubMed: 19076541.
16. Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, et al. (1997) Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 89: 3213-3218. PubMed: 9129025.
17. Maas C, Govers-Riemslag JW, Bouma B, Schiks B, Hazenberg BP, et al. (2008) Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 118: 3208-3218. PubMed: 18725990.
18. Scott CF, Shull B, Müller-Esterl W, Colman RW, (1997) Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA). Thromb Haemost 77: 109-118. PubMed: 9031459.
19. Govers-Riemslag JW, Smid M, Cooper JA, Bauer KA, Rosenberg RD, et al. (2007) The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost 5: 1896-1903. doi:10.1111/j.1538-7836.2007.02687.x. PubMed: 17723129.
20. Gallimore MJ, Friberger P, (1982) Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. Thromb Res 25: 293-298. doi:10.1016/0049-3848(82)90248-1. PubMed: 6917564.
21. Cugno M, Cicardi M, Coppola R, Agostoni A, (1996) Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology 33: 361-364. doi:10.1016/0162-3109(96)00086-0. PubMed: 8856187.
22. Loiseau C, Randriamahazaka HN, Nigretto JM, (1996) Explicit constants for the dextran-sulfate-mediated activation and autoactivation of purified human factor XII (Hageman factor). Eur J Biochem 239: 692-701. doi:10.1111/j.1432-1033.1996.0692u.x. PubMed: 8774715.
23. Cugno M, Nuijens J, Hack E, Eerenberg A, Frangi D, et al. (1990) Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 85: 1215-1220. doi:10.1172/JCI114555. PubMed: 2318974.
24. Nielsen EW, Johansen HT, Høgåsen K, Wuillemin W, Hack CE, et al. (1996) Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema. Scand J Immunol 44: 185-192. doi:10.1046/j.1365-3083.1996.d01-298.x. PubMed: 8711433.
25. Davis AE 3rd, (2008) Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol 100: S7-12. doi:10.1016/S1081-1206(10)60580-7. PubMed: 18220146.
26. Schousboe I, (2003) Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor. Eur J Biochem 270: 111-118. PubMed: 12492481.
27. de Smet BJ, de Boer JP, Agterberg J, Rigter G, Bleeker WK, et al. (1993) Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats. Blood 81: 56-61. PubMed: 8417802.
28. Wuillemin WA, Bleeker WK, Agterberg J, Rigter G, ten Cate H, et al. (1996) Clearance of human factor XIa-inhibitor complexes in rats. Br J Haematol 93: 950-954. doi:10.1046/j.1365-2141.1996.d01-1740.x. PubMed: 8703832.
29. Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, et al. (1988) Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. Blood 72: 1841-1848. PubMed: 3264190.
30. Joseph K, Tuscano TB, Kaplan AP, (2008) Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol 101: 279-286. doi:10.1016/S1081-1206(10)60493-0. PubMed: 18814451.
31. Heck LW, Kaplan AP, (1974) Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin. J Exp Med 140: 1615-1630. doi:10.1084/jem.140.6.1615. PubMed: 4547783.
32. Nilsson T, Bäck O, (1985) Elevated plasmin-alpha 2-antiplasmin complex levels in hereditary angioedema: evidence for the in vivo efficiency of the intrinsic fibrinolytic system. Thromb Res 40: 817-821. doi:10.1016/0049-3848(85)90318-4. PubMed: 2935973.
33. van Geffen M, Cugno M, Lap P, Loof A, Cicardi M, et al. (2012) Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency. Clin Exp Immunol 167: 472-478. doi:10.1111/j.1365-2249.2011.04541.x. PubMed: 22288590.
34. Shariat-Madar Z, Mahdi F, Schmaier AH, (2002) Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem 277: 17962-17969. doi:10.1074/jbc.M106101200. PubMed: 11830581.
35. Joseph K, Tholanikunnel BG, Kaplan AP, (2002) Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A 99: 896-900. doi:10.1073/pnas.022626899. PubMed: 11792853.
36. Joseph K, Tholanikunnel BG, Kaplan AP, (2009) Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol 124: 143-149. doi:10.1016/j.jaci.2009.02.006. PubMed: 19342086.
37. Dobo J, Major B, Kekesi KA, Szabo I, Megyeri M, et al. (2011) Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP). PLOS ONE-1: 6: e20036.